Clinical Trial Update: Study on the Safety and Efficacy of Cryopreserved Platelets in Hypoproliferative Thrombocytopenic Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial assessing safety and efficacy of cryopreserved platelets in patients with hypoproliferative thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoproliferative Thrombocytopenia

Snippet

Sponsor: Singapore General Hospital | Conditions: Hypoproliferative Thrombocytopenia | Phase 1, Phase 2 | Status: COMPLETED